Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.
about
Mitochondrial pyruvate transport: a historical perspective and future research directionsEffects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivoCancer treatment-related cardiac toxicity: prevention, assessment and management.Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.Anthracycline cardiotoxicity: prevalence, pathogenesis and treatmentMelissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 CellsHighly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.The role of antioxidants in the era of cardio‑oncology.A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis.The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma.Protective effects of vitamin E and Cornus mas fruit extract on methotrexate-induced cytotoxicity in sperms of adult mice.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm.Amino acid modified [70] fullerene derivatives with high radical scavenging activity as promising bodyguards for chemotherapy protection
P2860
Q28085025-443CC220-B529-41CC-B029-2953D03EF955Q28258783-900EB578-0EDA-443C-9D07-CA428A72464EQ30276456-A04AC81C-1478-4C7A-BEA6-0530A5DCC97CQ33897890-D7A1C717-12BB-4FF3-B199-524E9DE1C72DQ34639876-4E45E4F7-007A-4220-BE6F-5CB3F0533D91Q36202577-631AD870-D1B1-496B-A831-23E2FDCDF119Q36517999-60E4A5D9-00BA-4DC4-8C37-79C13E35EDBBQ37626273-C662A7D3-3EC6-4349-A0BD-F959C0EDD14CQ37720162-09D21D4C-CA25-493D-BF05-D27472962385Q38190105-40E41488-FD2E-428C-AA5C-6CD5B8183826Q41609905-E35E7C81-7B81-4BBE-A2D4-FE9B8D829376Q46171847-7F3BFB43-C223-4A25-A8C8-D2A1F05D87A3Q46805568-4A4144FF-7BFA-47A2-B2FD-2A6B1CF3CA53Q58589714-4402D01C-C466-4F67-A555-514E442B82B8
P2860
Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@en
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@nl
type
label
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@en
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@nl
prefLabel
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@en
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice.
@nl
P2093
P2860
P1476
Activity of d,l-alpha-tocopher ...... with cyclophosphamide in mice
@en
P2093
Jelena Radic
Sinisa Radulovic
Viktor Jovic
P2860
P304
P356
10.1111/J.1742-7843.2005.PTO_166.X
P577
2005-11-01T00:00:00Z